dokumendiregister.ee
OtsingAsutusedMCP
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel
Otsing›Ravimiamet
Sissetulev kiriAvalik

Küsimused

Ravimiamet · 2. jaanuar 2026
Viit
MSO-8/27-1
Registreeritud
2. jaanuar 2026
Dokumendi liik
Sissetulev kiri
Adressaat
Johnson & Johnson Consumer Services EAME Ltd
Saabumis/saatmisviis
e-post
Funktsioon
MSO Meditsiiniseadmed
Sari
MSO-8 Turujärelevalvega seotud nõustamine
Toimik
MSO-8/2026
Vastutaja
Karl Kalev Türk (RA, Meditsiiniseadmete osakond)

Failid

  • 📎MD change notification in Estonia.msg93 KB

Sisu (failidest)

Saatja: Hamed, Sarah [VISEU Non-J&J] <[email protected]> Saaja: RA MSO Teema: MD change notification in Estonia Dear Sir or Madam I am a Regulatory Affairs professional at J&J supporting the registration and compliance of medical devices in the EU. I would like to understand the post-registration change requirements in Estonia for changes such as: * Manufacturer or authorized representative address/name changes * CE certificate revisions (quality management or technical documentation) * Declaration of Conformity revisions * IFU or labeling updates (content, format, or translation) * Packaging or shelf-life changes * Product discontinuation If any of these changes are subject to notification, could you please advise: 1. Which documents must be submitted, 2. Through which portal or submission channel Thank you very much for your assistance in clarifying this matter. This will help ensure that we are fully aligned with Estonian regulatory requirements. Best regards, Sarah Hamed
Allikas: Ravimiamet dokumendiregister →